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The Bacillus cereus group contains vertebrate pathogens such as Bacillus anthracis and 
Bacillus cereus and the invertebrate pathogen Bacillus thuringiensis. Microbial 
biopesticides based on B. thuringiensis (Bt) are widely recognized as being among the 
safest and least environmentally damaging insecticidal products available. Nevertheless, 
a recent food poisoning incident prompted a European Food Safety Authority review 
which argued that B. thuringiensis poses a health risk equivalent to B. cereus, a 
causative agent of diarrhoea.   However, a critical examination of available data, and this 
latest incident, provide no solid evidence that B. thuringiensis causes diarrhoea. 
Although relatively high levels of B. cereus-like spores can occur in foods, genotyping 
demonstrates that these are predominantly naturally-occurring strains rather than 
biopesticides.  Moreover, MLST genotyping of >2000 isolates show that biopesticide 
genotypes have never been isolated from any clinical infection.  MLST data demonstrate 
that Bacillus cereus group is heterogeneous and formed of distinct clades with 
substantial differences in biology, ecology and host association.  The group posing the 
greatest risk (the anthracis clade) is distantly related to the clade containing all 
biopesticides. These recent data support the long-held view that B. thuringiensis, and 
especially the strains used in Bt biopesticides, are very safe for humans.   
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Introduction 
Let’s begin with a thought experiment. What would we, as scientists and regulators, like 
to know in order to be able confidently recommend a microbial control agent that is safe 
for application to growing crops?    We would need to be confident that the key active 
component of our biopesticide has no opportunity to interact with receptors on human 
cells.  We would like to know that these microbes are not able to infect vertebrates orally, 
by inhalation or via injection.  We would prefer that our microbe of choice did not 
associate with humans, even commensally, and it would be better if its biology and 
ecological niche were well described. If we were particularly cautious, we might like to 
hold off giving a firm scientific opinion until such a product had been used in the field for 
a number of years, perhaps for many decades.   
For the world’s best selling microbial pesticide, Bacillus thuringiensis, we have all this 
information (Federici and Siegel 2007, Siegel 2001).  Not only is B. thuringiensis (Bt) 
safe for vertebrates but a number of reviews, including an IOBC/WPRS working group, 
have concluded that Bt is also one of safest products available in terms of impacts on 
non-target insects (Glare and O'Callaghan 2000, Hassan 1992).  Bt is therefore an 
important environmentally friendly part of the modern pest management tool-kit.  The 
only other group of pesticides that may be safer are baculovirus products, which 
typically have a very narrow host range such as an insect genus or species (Huber 
1988), and constitute a very minor market because they must be produced in caterpillars.   
Despite decades of accumulated biological, ecological and safety data the use of B. 
thuringiensis (Bt) is now under threat in Europe.    Significantly, this change of heart on 
the part of the European regulators (European Food and Safety Authority- EFSA) is not 
based on new scientific evidence, but rather on an isolated and highly publicized 
incident of food-poisoning in Germany, in which Bt was not identified as the etiological 
agent with any degree of reliability (EFSA 2016).  This isolated case led to a new 
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working group, which reached the contentious, and in our view erroneous conclusion 
that Bacillus thuringiensis is biologically and ecologically equivalent to Bacillus cereus, a 
known cause of human food-poisoning (Granum and Lund 1997, Stenfors Arnesen, et al. 
2008), since both are close relatives in the B. cereus group.  Currently, Bt and B. cereus 
are typically distinguished using a single phenotypic character, the production of 
inclusion bodies composed of crystal (Cry) proteins encoded by genes on large 
plasmids (Gonzalez, et al. 1981). Many (but not all) Bt strains are chromosomally similar 
to strains of B. cereus  (Figure 1) (Raymond and Bonsall 2013).  Notably, the presence 
of absence of cry genes is not a very reliable indicator of how strains have been 
classified (Liu, et al. 2015), either because of the presence of pseudogenes or because 
the phenotypic definition has not been carefully applied.   Nevertheless, the ecological 
distinctiveness of Bt as a group of specialized invertebrate pathogens has been widely 
accepted by most experts and regulatory agencies for decades (Raymond, et al. 2010a, 
Ruan, et al. 2015) and is formally recognized through the different hazard levels 
assigned to each species: Biohazard level 1 (for Bt) and Biohazard level 2 (for B. cereus 
as an opportunistic pathogen).  Thus, arguments over the taxonomic status of Bt and its 
ecological and biological identity have been a major cause of this latest controversy. 
In addition, the recent EFSA opinion encompassed a broad, but uncritical review of the 
Bt and B. cereus literature and came to conclusions about the ability of Bt to infect 
humans that differ markedly from previous analyses (Federici and Siegel 2007, Glare 
and O'Callaghan 2000, Siegel 2001).  Importantly, they make the poorly substantiated 
claim that we are largely ignorant of the ability of Bt to infect vertebrates and thus should 
treat it as of equivalent risk to humans as B. cereus based on the precautionary principle.  
Here, we challenge the conclusion that we are ignorant of Bt’s biology; point out new 
evidence supporting its safe track record that has appeared since the last major reviews 
of this topic; show how the ESFA Opinion article distorts the data on Bt strains in foods 
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and biopesticides implying it may be a significant cause of food poisoning; and dispute 
the idea that the B. cereus group is biologically and ecologically homogeneous. 
How the trouble started – from molehill to mountain 
The details of the case of food poisoning that prompted the recent EFSA enquiry are 
worth repeating.  In July 2012, a German family of five ate a meal of cheese noodles; 
three members of the family also ate a salad and these three members became ill with 
diarrhoea (EFSA 2016).   Food samples were analyzed for presumptive causative 
agents: the salad contained 3x104 CFU g-1 of B. thuringiensis; the cheese noodles 
contained 6.0 x 103 CFU g-1 of B. cereus. The Bt was identified as being 
indistinguishable from the B. t. aizawai strain that is the active ingredient of the 
biopesticide XenTari applied to the salad crops in question.  Repeat sampling of the 
salad from the supermarket where the original product was purchased found Bt 
concentrations of 4x104 CFU g-1 and 1.5x105 CFU g-1.   
This level of evidence cannot reliably implicate Bacillus thurigiensis (Bt) as the cause of 
infection as there are two possible etiological agents involved.  However, we can use the 
scientific literature to assess the balance of probabilities in favour of one agent or 
another.  Is the fact that 3/5 individuals became ill after consuming cheese noodles 
contaminated with B. cereus (Bc) consistent with Bc being the causative agent?  
Estimates of the infective dose of Bc required to establish an infection vary widely but 
commonly cover the 105-107 CFU g-1 range (Stenfors Arnesen, et al. 2008).  
Nevertheless, concentrations as low 102-103 in food have been found associated with 
disease (Stenfors Arnesen, et al. 2008).  Moreover, basic epidemiological principles 
assert that there is no one “infective dose” for pathogens, but a dose-response curve in 
which increasing doses lead to a higher probability of infection, which is well described 
for Bt (Cornforth, et al. 2015).  Even if 103-104 CFU g-1 constitutes a low dose of B. 
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cereus, an infection rate of 60% is entirely consistent with what we know of this 
organism and of epidemiology in general.   The fact that the three individuals who 
became ill also happened to eat the salad could therefore be a coincidence.  Using 
simple probability theory, we can calculate precisely how much of a coincidence this 
was.   There are 5!/(3!(5-3)! ways, i.e. only 10 ways, of choosing 3 individuals from a 
family of 5.  In only one out of these 10 combinations would all three infected individuals 
be the same individuals that ate the salad: giving us a probability of 0.1. In the scale of 
unlikely events, a probability of 10% is a rather ordinary coincidence, one that would not 
meet the bar of statistical significance, and which is particularly modest given that ten of 
thousands of families across Europe eat tomatoes and other vegetables that have been 
sprayed with Bt products (Frederiksen, et al. 2006, Rosenquist, et al. 2005).   Direct 
evidence to implicate Bt rather than Bc as a cause of diarrhoea, for example evidence of 
Bt proliferation from stool samples, was not provided.   
Safety testing of Bt in vertebrates.  
On the other hand, how likely is it that the alternative hypothesis is correct, i.e. that B. t. 
aizawai was actually the cause of infection in the case above?  Leaving the debate on 
whether any strains of Bt can cause vertebrate infections until later, let us first consider 
whether biopesticidal strains of Bt can cause infections in humans.  Here, we will largely 
summarize the main points from previous reviews of the biosafety of Bt (Federici and 
Siegel 2007, Siegel 2001). For instance, between 1961 and 1995 the United States 
Environmental Protection Agency licensed 177 products that used Bt spores and Cry 
crystals as active ingredients; all were tested for infectivity in mammals (McClintock, et al. 
1995, Siegel 2001). While licensed products can cause mortality in vertebrates at very 
high doses, there is a threshold dose above which pathogens are considered safe. In the 
U.S. this is a dose of 106 spores into a mouse. However, in general doses of Bt required to 
kill small mammals by injection/gavage are typically greater than 108 spores, which for 
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humans would be equivalent to a dose in the region 1011 spores (Siegel 2001).  To put this 
in perspective, that would be the dose found on approximately 10,000 kg of the salad in 
the above German food poisoning incident.   
Notably, it is hard to find evidence of oral doses of Bt biopesticides that are high enough 
to cause any infection or other symptoms in vertebrates.   Rats fed 109 spores per day 
for 730 days successfully suffered no ill-effects (Siegel 2001);  doses of 1012  have no 
effects on sheep or rats (Siegel 2001).  The rat study in particular assessed six different 
strains over three weeks.  A concentration of 1010 CFU ml-1 does not affect mice (Berlitz, 
et al. 2012) and over five days human volunteers can consume 1g per day 
(approximately 1011 spores) of a formulated product (Thuricide) based on B. t. 
thuringiensis without ill effects (Siegel 2001). Epidemiological studies confirm the results 
of acute toxicity tests.  The city-wide application of Bt to Auckland in New Zealand and to 
Victoria in British Columbia did not result in detectable impacts on health problems in 
comparison to unsprayed areas of those cities, although elevated levels spores of Bt 
kurstaki could be recovered from the nasal swabs of inhabitants, confirming that there 
had been exposure (Federici and Siegel 2007). 
The occurrence of Bt and Bc in food and the environment 
Given the above experimental studies on the safety of B. thuringiensis to vertebrates it is 
relevant to note the rates and composition of Bt products used commonly to control 
caterpillar pests in organic agriculture and integrated pest management (IPM) programs. 
Unlike most synthetic chemical insecticides, Bt biopesticides can be applied as late as 
the day before harvest because of their record of safety. Products like Biobit, Dipel, 
Foray, and Thuricide, as well as many others used in different countries around the 
world are based on the HD-1 isolate of B. t. kurstaki.  In addition to viable spores, these 
products contain four insecticidal proteins, Cry1Aa, Cry1Ab, Cry1Ac, and Cry2Aa 
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(Crickmore, et al. 1998, Schnepf, et al. 1998). Similarly, most commercial B. t. aizawai 
products are based on the HD-133 or a similar isolate, which contains viable spores and 
four Cry proteins, namely, Cry1Aa, Cry1Ac, Cry1C, and Cry1D (Kuo and Chak 1996). 
The concentrations of viable spores in products based on the above Bt kurstaki and 
aizawai strains are typically in the region of 106 mg-1. Biopesticide label 
recommendations state these can be sprayed at coverage rates from 0.01 to 0.1 mg per 
cm2, or in other words, about 10,000 to 100,000 spores per cm2 of crop surface area. In 
addition to the active ingredients, commercial products contain dried spent fermentation 
media, and protective efficacy enhancers, commonly referred to as UV protectants, and 
spreaders and stickers to enhance adherence of the spores and Cry crystals to crops so 
they are not washed off by rain or overhead irrigation. Many vegetables including 
tomatoes, celery, and cucumbers are eaten raw, and if sprayed with Bt products, these 
adherence enhancers make it difficult to wash the spores and Cry crystals off the crop.  
Thus, it is not surprising that CFUs in the range of 103 -106 gm-1 are found on fresh 
vegetables in supermarkets. Even given the possible effects of vegetable washing, if 
consuming up to 106 gm-1 Bt spores caused diarrhoea we would expect at least people 
who consume organic crops to routinely report this illness; however, there are no data 
supporting this. 
 The EFSA Opinion paper attempted to raise questions about the safety of Bt and Bt 
biopesticides by focusing on data in two peer-reviewed studies that deal with the 
occurrence of B. thuringiensis in food (Frederiksen, et al. 2006, Rosenquist, et al. 2005).  
Two other studies dealing with a limited number of food poisoning events in which Bt 
was implicated as the causative agent are discussed below (Jackson et al., 1995; 
McIntyre et al., 2008).  The data reviewed are accurate. However, the interpretations are 
misleading, if not wrong, with respect to the source of the Bt strains identified - naturally 
occurring or from Bt biopesticides - and whether the latter actually caused disease.   In 
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this regard, the data published by Rosenquist, et al. (2005) and Frederiksen, et al. 
(2006) on ready-to-eat foods in Danish markets are relevant. In the Rosenquist et al. 
(2005) study 0.5% of food samples had counts of Bt/Bc higher than 104 CFU/g, a level 
considered unacceptable for human consumption under Danish guidelines.  These high 
counts were found in fresh tomatoes, cucumbers and heat-treated ready-to-eat starchy 
foods, especially desserts containing rice, nuts, and milk.  Of 40 strains tested for 
parasporal Cry crystals and cry genes, 31 were positive, allowing these to be identified 
as Bt, and all contained genes for protein enterotoxins that could cause diarrhoea.  
Based on these results, the authors concluded “These observations indicate that B. 
thuringiensis could actually be responsible for many of the food borne outbreaks here 
previously attributed to B. cereus sensu stricto.”  This conclusion is misleading primarily 
because there is no evidence for food poisonings resulting from high counts of Bt in food.  
It would also be erroneous for a regulator to infer from these studies that limiting spray 
residues on crops would substantially reduce the exposure to Bt in food.  For example, 
only 5 of the 40 strains (12.5%) tested had profiles characteristic of Bt biopesticides.  
Another flaw in the study is that the PCR tests only screened for two cry genes (cry1Aa 
and cry1Ab) that occur widely in many natural Bt isolates (Crickmore, et al. 1998) so 
these tests are not sensitive enough to reliably identify any strain as having a 
biopesticidal origin.  In the follow-up study, Frederiksen, et al. (2006) used plasmid and 
cry gene profiles to determine if B. cereus group strains had genotypes identical to those 
of Bt biopesticides.  Fredriksen et al., 2006 found that had 18% of the 128 isolates had 
plasmid profiles characteristic of Bt strains used in commercial products.  When these 
genotypes were present in high concentrations (CFU >10,000 g-1), these strains 
originated from cucumber or cherry tomatoes.  These are not starchy foods in which the 
spores are likely to germinate or vegetative cells are prone to multiply, and thus are 
highly unlikely to result in food poisoning.  More importantly with respect to use of Bt 
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biopesticides, these data show that between 80 and 90% of isolates were from natural 
isolates of Bt rather than biopesticide strains (Frederiksen, et al. 2006, Rosenquist, et al. 
2005). What is not mentioned in the EFSA Opinion paper is the common occurrence of a 
wide array of Bt strains in all kinds of stored grains and nuts (Burges and Hurst 1977, 
Itova-Aoyolo 1995, Meadows, et al. 1992) most of which do not have the specific gene 
profiles of Bt biopesticides.  Thus, grains and nuts, and dusts from storage granaries are 
the probable source of the naturally occurring Bt strains commonly found in ready-to-eat 
foods studied from Danish markets.     
Bt and human infections: case studies and new epidemiological data. 
What then if we cast our net more broadly, is there evidence that any strain of Bt can 
cause gastrointestinal or tissue infections in vertebrates.  The number of infections in 
humans where Bacillus thuringiensis strains are a clear causative agent are extremely 
few, if any.  Bt has been recovered from infected burn wounds (Damgaard, et al. 1997),  
and in one instance from a soldier severely injured by a land mine (Hernandez, et al. 
1998) and from a pulmonary infection (Ghelardi, et al. 2007).  However, none of these 
were biopesticidal isolates.  The konkukian strain isolated from the wounded soldier can 
be reliably placed in the anthracis clade, as can the RM1 strain isolated from lung tissue 
(ST386) - a group known for its ability to infect vertebrates (Figure 1) (Raymond and 
Bonsall 2013).  In one report, a farmer developed a corneal ulcer after being splashed in 
the face with Dipel, a Bt kurstaki product, and Bt was recovered from that ulcer 
(Samples and Buettner 1983). However, in that incident the farmer applied a 
corticosteroid lotion to his eye before the ulcer developed.  Corticosteroids can suppress 
the immune system and delay would healing, so in this case the Bt spores may have 
simply persisted in the eye without being the main cause of infection (Siegel 2001).  The 
EFSA opinion also cites Helgason, et al. (2000a), claiming it shows that Bt was found 
associated with periodontal infections.  In fact, that study identified only one isolate of Bt, 
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which was recovered from a dairy farm and not a human infection (Helgason, et al. 
2000a).  A second study cited described how two Bt strains were recovered from the 
blood of immune-compromised patients, but the genotyping scheme used could not 
confirm they were biopesticidal strains (Kuroki, et al. 2009).    
The EFSA opinion takes a very uncritical interpretation of key data in the Bacillus 
literature. In the 39 food-poisoning outbreaks studied by McIntyre, et al. (2008), B. 
thuringeinsis occurred in food consumed in four of these outbreaks (10%) based on 
detection of cry genes and crystals. Although Bt could be recovered from food it was 
never found in clinical stool specimens, unlike B. cereus (McIntyre, et al. 2008).  Given 
the high prevalence of Bt on plants and on sprayed crops, and the expectation that Bt 
would have to replicate in the gut in order to cause infection (Ceuppens, et al. 2012b), it 
can not be concluded that Bt was the causative agent from these data.  We would 
therefore disagree with EFSA’s interpretation of this article as describing “B. 
thuringiensis related food poisonings” (p 22, para 3.2.2).  In the earlier study by Jackson, 
et al. (1995), stools from 18 individuals during a food poisoning outbreak were examined, 
and in four of these people the samples had crystals and a phage type characteristic of 
Bt, but also the presence of a more plausible etiological agent, Norwalk virus. Neither 
study provided data, nor was it claimed that the Bt strains identified caused the 
outbreaks or were from Bt biopesticides. In summary, all cases in which Bt was 
recovered from infection are associated with immune-suppression, either as the result of 
burning, massive trauma, or medical treatment and there is no convincing evidence that 
any of the strains studied were the cause of diarrhoea.   
Despite the abundance of studies and data produced over the past 50 years supporting 
the safety of Bt, the EFSA opinion makes the startling claim that the “actual contribution 
of the two species [B. cereus and B. thuringiensis] to gastro-intestinal and non-
gastrointestinal diseases in currently unknown.” The basis for this statement is that 
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clinical laboratories do not routinely screen B. cereus isolates for Cry inclusion bodies 
and therefore it is not known whether these infections were caused by Bt or B. cereus. 
This claim ignores the substantial data sets on clinical B. cereus group infections that 
have emerged since the application of multi-locus-sequence typing (MLST) (Maiden, et 
al. 1998, Priest, et al. 2004). MLST schemes for B. cereus vary, but the original scheme 
used 7 loci, covering 2838 bp of house keeping genes widely distributed across the 
genome (Priest, et al. 2004).  While MLST techniques are being replaced by whole 
genome sequencing, the older methods are still a sensitive tool for distinguishing 
chromosomal genotypes and have yielded substantial databases on thousands of 
isolates over more than ten years.  
Most importantly for this discussion, the key Bt biopesticide strains have recognizable 
sequence types (STs) that are not shared with any known Bc strains (Table 1).   Given 
the levels of biopesticide spores in food and in the environment, if biopesticidal Bt 
strains were causing infections we would expect to see their chromosomal sequence 
types in clinical infections. Queries of the Bacillus cereus pubMLST website 
(http://pubmlst.org/ bcereus/), which defined the above sequence types (Jolley and 
Maiden 2010), or the combined SUPERCAT B. cereus database (Tourasse, et al. 2010) 
has not identified a single case, to date, where a clinical infection or case of diarrhoea 
was associated with one of the Bt biopesticide sequence types.  While there is still some 
ambiguity about the appropriate sequence type of the Bt aizawai strain in the product 
XenTari - no aizawai strain has ever been associated with a vertebrate infection.   The 
SUPERCAT database contains data on 2341 isolates, 490 of which have been 
recovered from vertebrate infections or which carry the pX01 or pX02 anthracis virulence 
plasmids.  
Again, we can cast our net more broadly to determine if any STs described as B. 
thuringiensis have ever been associated with clinical infections. Here we focus on 
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isolates in Clade 2, as those in the ‘anthrax’ clade or Clade 1 can already be assumed 
more dangerous for vertebrates (Figure 1).  In Clade 2 there are only a few genotypes 
that have been recovered from both clinical sources and described by others as Bt 
(pakistani ST18 and darmstadiensis ST56), as well as a Bc genotype corresponding to B. 
thuringiensis HD-771 described by Tourasse, et al. (2006).  Other genotypes initially 
reported as being comprised of mixtures of Cry producers and non-producers (Raymond, 
et al. 2010b) have subsequently proven to be mixtures of different genotypes (B. 
Raymond unpul. dat.). Thus, only a handful of isolates have a genotype potentially 
associated with Cry inclusions in one context and in another context of infecting humans.  
It is entirely plausible that possession of Cry toxin bearing plasmids was a transient or 
recent occurrence in these genotypes and that infections in humans were associated 
with clones that lack Cry toxin synthesis.  Database entries are also subject to error. 
These genotypes and clones are certainly not well studied, and published reports on 
these genotypes contain no details about their origins or how strains were typed as Bt. 
In summary, we have a great deal of data on whether or not Bt genotypes are 
associated with clinical infections.  The fact that not one of the numerous clinical 
infections associated with B. cereus sensu lato has ever been found to be caused by 
biopesticide genotype confirms the results of decades of safety testing and city-wide 
epidemiological studies.   The fact that only a very small number of clinical isolates 
subject to MLST testing have ever been shown to be genotypically indistinguishable 
from clones also described as B. thuringiensis should also give us confidence. 
Phylogeny is a better indicator of infection risk for vertebrates than carriage of 
enterotoxin genes  
Some B. cereus specialists, as well as the EFSA opinion, make the argument that Bt 
could be dangerous to vertebrates because these bacteria carry haemolytic enterotoxin 
genes that are thought to be responsible for the ability of B. cereus to cause diarrhorea 
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(EFSA 2016, Granum and Lund 1997, Stenfors Arnesen, et al. 2008). It is very important 
to note that it is the emetic B. cereus strains that cause the most serious cases of food 
poisoning due to the production of the distinct cereulide toxin, and these strains are 
largely restricted to a narrow set of lineages and no Bt strain have ever been found to be 
capable of producing cereulide (Agata, et al. 1996, Thorsen, et al. 2006, Vassileva, et al. 
2007)(Figure 1).  The argument that Bt strains are dangerous because they carry 
enterotoxins does not hold up to scrutiny.  Firstly, most if not all biopesticide strains, 
such as those based on Bt kurstaki HD-1 carry enterotoxin genes and score positively 
on ELISA assays for these proteins, but this is not associated with the ability to infect 
vertebrates (Bishop, et al. 1999, Damgaard 1995).  The evidence linking possession of 
enterotoxin genes to clinical risk is also circumstantial.  Enterotoxin gene profiles vary 
considerably across the B. cereus group (Cardazzo, et al. 2008). Hemolytic toxins tend 
to be absent from lineages containing Bacillus mycoides and Bacillus 
weihenstephanensis (Cardazzo, et al. 2008), which is consistent with the view that these 
are non-pathogenic environmental groups (Raymond and Bonsall 2013, Raymond, et al. 
2010b)(Figure 1).  Gastro-intestinal simulation experiments failed to demonstrate 
enterotoxin production during growth conditions mimicking that in the ileum (Ceuppens, 
et al. 2012a), and none of the four major classes of enterotoxin genes are critical for 
infection in insects (Klimowicz, et al. 2010). Nevertheless, regulation of enterotoxin 
genes is complex.  The presence of one enterotoxin gene may be required for food 
poisoning potential but the possession of even multiple genes is not sufficient to indicate 
the ability to cause intestinal infections in vertebrates (Cardazzo, et al. 2008). 
In fact, phylogenetic affiliation within the B. cereus is a much better indication of 
ecological niche or food poisoning risk (Guinebretière, et al. 2010, Raymond and Bonsall 
2013, Raymond, et al. 2010b).  While some of earlier literature argues that the B. cereus 
group is homogeneous (Helgason, et al. 2000b) or that B. cereus, B. thuringiensis and B. 
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anthracis should be considered one single species (Tourasse, et al. 2006), this most 
certainly does not represent a consensus.  In fact, application of MLST has led to the 
opposing consensus view: that there are substantial genetic and biological differences 
between clades in the B. cereus group, (Cardazzo, et al. 2008, Didelot, et al. 2009, 
Priest, et al. 2004, Raymond and Bonsall 2013, Raymond, et al. 2010b, Siegel 2001, 
Sorokin, et al. 2006, Vassileva, et al. 2006), while also recognizing that these clades do 
not neatly correspond to given species names.  Analyses of the patterns of horizontal 
gene transfer suggest that there are at least three major clades and that most 
recombination occurs within rather than between clades (Didelot, et al. 2009). One 
recent whole genome analysis suggests breaking up the group into 19 or 20 species 
might be justified (Liu, et al. 2015), a recommendation that is perhaps a step too far.  
Importantly the major MLST clades have different patterns of host association or varying 
ability to cause food poisoning (Figure 1) (Guinebretière, et al. 2010, Raymond and 
Bonsall 2013, Raymond, et al. 2010b).  Since Bt strains (producing Cry toxins) are 
widely distributed in several clades, not all Bt strains would be expected to be equally 
safe, as the discussion above suggests.  Strains more closely related to anthracis are 
more commonly associated with vertebrate infections, giving us an expectation of 
greater risk.  These phylogenetic analyses support the data from acute safety tests 
demonstrating that B. anthracis is at least one million times more dangerous to 
vertebrates than biopesticidal stains of Bt (Siegel 2001).  Critically, lineages containing 
the biopestide strains from the serovars israelensis, morrisoni (strain tenebrionis), 
kurstaki and aizawai are unlikely to be associated with human infection (Figure 1).  The 
latest information available in the SuperCat database confirm these earlier analyses: 
72% of the 548 isolates in the anthracis clade  (clade 1 or cluster III) either closely 
resemble B. anthracis itself or have been associated with vertebrate infections, while 
only 29% of the 866 isolates in clade 2 are associated with vertebrate infections.  This 
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variation in host range and ecology between different clades within the B. cereus group 
was inadequately discussed in the EFSA review.  
The production of Cry toxins is ecologically and biologically significant. 
The fact that Cry toxins are plasmid encoded (and can therefore move between 
distantly related lineages) is almost certainly the reason why Bt and Bc do not form tidy, 
distinct species.  Nevertheless, the different names can still be useful because the 
ecological and biological consequences of producing Cry toxins are profound.  Since Bc 
enterotoxins can be degraded by stomach acids and digestive enzymes, it is thought 
that their presence must be the result of new vegetative growth in the lower intestine 
(Ceuppens, et al. 2012b).  A key barrier to infection success in B. cereus is competition 
with existing gut microbes (Ceuppens, et al. 2012b).  The carriage of Cry toxin plasmids 
substantially weakens the competitive ability of Bt relative to that of Bc in vivo (Raymond, 
et al. 2007, Raymond, et al. 2012) and in soil (Yara, et al. 1997).  Poor competitive 
ability is likely to make B. thuringiensis substantially less fit in the gut of vertebrates, 
where Cry toxin production is not adaptive. While entomocidal Bt strains appear to have 
specific adaptations that enable them to compete effectively with aerobic intestinal 
microbes in the invertebrate gut (Raymond, et al. 2009, Raymond, et al. 2008) the 
production of Cry toxin, or the carriage of Cry toxin bearing plasmids, may explain the 
reduced ability to cause infections in the vertebrate intestine.  
Conclusion. 
To summarize, the recent controversial case of food poisoning in Germany presents no 
convincing evidence that Bt was the causative agent, since individuals with food 
poisoning had also consumed a dose of B. cereus sufficient to cause the observed level 
of infection.  Overall, the MLST databases, the epidemiological studies and safety 
testing literature present a well-informed and coherent view of the biology and ecology of 
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the B. cereus group. The argument  in the EFSA report, that we do not understand the 
risks of consuming Bt spores, are therefore unfounded and overly cautious. An analysis 
of studies cited in EFSA’s opinion used to question Bt safety (Rosenquist et al., 2005; 
Frederiksen et al., 2006), show not only do humans routinely eat high levels of this 
species, but that most of the strains (> 80%) consumed are naturally occurring, not from 
biopesticides. Yet even at rates not considered acceptable under Danish guidelines, 
there is no evidence that consumption has ever resulted in food poisoning. Furthermore, 
strains of entomocidal Bt are not capable of infecting vertebrates at extremely high 
doses in controlled laboratory tests and there are no robust data to suggest that humans 
might be an exception.   Phylogenetic analyses of ecological differentiation across the B. 
cereus group suggest that there are very few strains of Bt with elevated risks for 
vertebrates (Guinebretière, et al. 2010, Raymond and Bonsall 2013, Raymond, et al. 
2010b).  This would include the subsp. konkukian, which was originally isolated from a 
soldier severely injured by a land mine (Hernandez, et al. 1998).  That isolate did indeed 
pose a greater risk to mice than biopesticidal strains of Bt (Hernandez, et al. 2000).  
Crucially, the Bt konkukian can be firmly placed in the anthracis clade and is distantly 
related to all the biopesticidal strains (Han, et al. 2006, Raymond and Bonsall 2013, 
Raymond, et al. 2010b); it is also not demonstrably pathogenic to insects.  Based on the 
ecological differentiation across the B. cereus group we would not recommend licensing 
any Bt products that show a similar biological affinity to B. anthracis.   
Regulators do not have a particularly easy job.  For plant protection products, be they 
chemical or biological, it is never possible to eliminate risk entirely.  Making the 
argument that we do not know enough to assure governments of a reasonable level of 
safety is therefore tempting.  Recommendations for greater levels of precaution can 
always be justified.  However, a highly cautious approach has consequences in terms of 
the ever-narrower range of products available to growers or the increasing costs 
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associated with pest management.  Without doubt, we do need to control pests but ever 
greater levels of restriction are likely to make the horticultural and agricultural economy 
of the European Union increasingly uncompetitive.  Moreover, tighter restrictions on the 
use of Bt products will mean that growers will return to the use of registered broad-
spectrum synthetic chemical insecticides, which without question are more harmful to 
the environment. Regulators must therefore carefully weigh the balance of evidence 
before urging greater restrictions.  For Bt, there is simply no case for increasing 
restrictions on this valuable, highly safe biological insecticide.  
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Table 1. The sequence types associated with the major Bt serovars used in insect pest 
management are all recovered from insect and environmental sources.   Unique 
sequence ST numbers are defined here according to unique allele profiles in the MLST 
scheme developed by Priest et al. (2004) and hosted by pub.mlst.org.  Origins of 
isolates matching the allelic profiles of these biopesticidal strains were explored: all were 
recovered from or environmental material (plants, soil), none were recovered from 
human clinical studies.  Total strains in the pub.mlst database: 2095:  18 from diarrhoea;  
42  from faeces;  47 blood;  5 vomit ;  9 respiratory tract ; 7 wound.  These sequences 
types were matched to the broader SuperCAT database that compiles information from 
all the available MLST schemes of the B. cereus group as well as whole genome data 
(http://mlstoslo.uio.no) .  Information on the origin and characteristics of isolates were 
determined from the above databases or from references listed for isolates.   
Product 
names 
Bt serovar isolate synonyms ST isolates with identical 
allele profile in 
SuperCAT (and 
pub.mlst) databases 
DiPel 
BMP 123 
Thuricide 
kurstaki HD-1 8 79 (74) 
XenTari, 
Florbac,  
aizawai T07033 / HD227 
 
15*  8 (7) 
Novodor morrisoni BGSC4AA1 
biovar. tenebrionis 
23 23 (21) 
Tekar, 
VectoBac, 
Aquabac 
israelensis BGSC4Q1,ONR60A, H-
14, ATCC 35646 
16† 6  
Tekar, 
VectoBac, 
israelensis 
 
BGSC4Q7 
HD1002 
16 21 (13) 
*not confirmed: other aizawai sequence types (STs) include 53, 54, 833, 834 
† closest match based on available allelic profile: gmk 7; ilv7; pta 2; pur 6; pyc 8; tpi 13 
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Figure 1.  Variation in ecology, host and habitat association across distinct clades in the 
B. cereus group.  The phylogeny was based on the Priest et al. (2004) MLST scheme 
and constructed using CLONALFRAME  and redrawn from the analysis in Raymond et 
al. (2010).  The pie charts describe the proportion of isolates with particular host-
associated (Cry toxins, pXO1/XO2 plasmids) traits or their habitat and host of origin; the 
colour-coded text at the top of the figure explains the affiliations; the arcs in bold black 
describe the extent of the clades or sub-clades.  Pie charts summarize data for the two 
major sub-groups of clade 1 and three major groups of clade 2.  Key vertebrate and 
invertebrate associated Sequence Types are indicated around the tree; red indicates 
vertebrate association.  Sequence types labeled in gold with a serovar and the epithet 
cereus are genotypes that have been described as both B. cereus and B. thuringiensis; 
ST14 is also the B. cereus type strain.  The abbreviation ‘myc’ refers to genotypes that 
have been described as Bacillus mycoides.  Clade 1 corresponds to cluster III in the 
Guenebretiere (2010) scheme, Clade 2 to cluster IV and Clade 3 to cluster II and 
pseudomycoides indicates the position of cluster I. 
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